Faccenda V - Search Results

1

Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking.

Lucchini R, Panizza D, Colciago RR, Vernier V, Daniotti MC, Faccenda V, Arcangeli S. Lucchini R, et al. Among authors: faccenda v. Radiat Oncol. 2021 Sep 17;16(1):180. doi: 10.1186/s13014-021-01908-0. Radiat Oncol. 2021. PMID: 34535168 Free PMC article.

2

Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy.

Panizza D, Faccenda V, Lucchini R, Daniotti MC, Trivellato S, Caricato P, Pisoni V, De Ponti E, Arcangeli S. Panizza D, et al. Among authors: faccenda v. Front Oncol. 2022 Apr 7;12:883725. doi: 10.3389/fonc.2022.883725. eCollection 2022. Front Oncol. 2022. PMID: 35463373 Free PMC article.

3

Lexicographic optimization-based planning for stereotactic radiosurgery of brain metastases.

Trivellato S, Caricato P, Pellegrini R, Daniotti MC, Bianchi S, Bordigoni B, Carminati S, Faccenda V, Panizza D, Montanari G, Arcangeli S, De Ponti E. Trivellato S, et al. Among authors: faccenda v. Radiother Oncol. 2024 Apr 25;196:110308. doi: 10.1016/j.radonc.2024.110308. Online ahead of print. Radiother Oncol. 2024. PMID: 38677330 Free article.

4

Treatment Optimization in Linac-Based SBRT for Localized Prostate Cancer: A Single-Arc versus Dual-Arc Plan Comparison.

Panizza D, Faccenda V, Arcangeli S, De Ponti E. Panizza D, et al. Among authors: faccenda v. Cancers (Basel). 2023 Dec 19;16(1):13. doi: 10.3390/cancers16010013. Cancers (Basel). 2023. PMID: 38201441 Free PMC article.

5

Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study.

Ferrario F, Franzese C, Faccenda V, Vukcaj S, Belmonte M, Lucchini R, Baldaccini D, Badalamenti M, Andreoli S, Panizza D, Magli A, Scorsetti M, Arcangeli S. Ferrario F, et al. Among authors: faccenda v. Clin Transl Radiat Oncol. 2023 Nov 25;44:100704. doi: 10.1016/j.ctro.2023.100704. eCollection 2024 Jan. Clin Transl Radiat Oncol. 2023. PMID: 38111610 Free PMC article.

6

Short-term pain control after palliative radiotherapy for uncomplicated bone metastases: a prospective cohort study.

Bianchi SP, Faccenda V, Pacifico P, Parma G, Saufi S, Ferrario F, Belmonte M, Sala L, De Ponti E, Panizza D, Arcangeli S. Bianchi SP, et al. Among authors: faccenda v. Med Oncol. 2023 Dec 11;41(1):13. doi: 10.1007/s12032-023-02238-9. Med Oncol. 2023. PMID: 38079079

7

Updating approach for lexicographic optimization-based planning to improve cervical cancer plan quality.

Caricato P, Trivellato S, Pellegrini R, Montanari G, Daniotti MC, Bordigoni B, Faccenda V, Panizza D, Meregalli S, Bonetto E, Voet P, Arcangeli S, De Ponti E. Caricato P, et al. Among authors: faccenda v. Discov Oncol. 2023 Sep 30;14(1):180. doi: 10.1007/s12672-023-00800-5. Discov Oncol. 2023. PMID: 37775613 Free PMC article.

8

Single-Isocenter Linac-Based Radiosurgery for Brain Metastases with Coplanar Arcs: A Dosimetric and Clinical Analysis.

Faccenda V, Panizza D, Pisoni V, Trivellato S, Daniotti MC, Bianchi SP, De Ponti E, Arcangeli S. Faccenda V, et al. Cancers (Basel). 2023 Sep 10;15(18):4496. doi: 10.3390/cancers15184496. Cancers (Basel). 2023. PMID: 37760466 Free PMC article.

9

Dosimetric Impact of Intrafraction Prostate Motion and Interfraction Anatomical Changes in Dose-Escalated Linac-Based SBRT.

Faccenda V, Panizza D, Daniotti MC, Pellegrini R, Trivellato S, Caricato P, Lucchini R, De Ponti E, Arcangeli S. Faccenda V, et al. Cancers (Basel). 2023 Feb 10;15(4):1153. doi: 10.3390/cancers15041153. Cancers (Basel). 2023. PMID: 36831496 Free PMC article.

10

Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial.

Lucchini R, Franzese C, Vukcaj S, Purrello G, Panizza D, Faccenda V, Andreoli S, Poli GL, Baldaccini D, Lo Faro L, Tomatis S, Cazzaniga LF, Scorsetti M, Arcangeli S. Lucchini R, et al. Among authors: faccenda v. Curr Oncol. 2022 Nov 30;29(12):9349-9356. doi: 10.3390/curroncol29120733. Curr Oncol. 2022. PMID: 36547147 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page